Dry Eye Medication Market Healthcare Analysis and Research Report 2020-2030 | Allergan plc (NYSE: AGN).; Alcon Inc; Novartis AG

The Dry Eye Medication Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2030. The Dry Eye Medication Market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. This Dry Eye Medication Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Overview: Growth in the historic period resulted from an aging population, a rising number of contact lens users, and increase in disposable income, increase in number of treatment options and an increased number of allergies. Factors that negatively affected growth in the historic period were low healthcare access and a lack of awareness of the dry eye medication products amongst the common population.

Going forward, rising laser surgeries, rising screen time, busy lifestyles, the increasing burden of diabetes, increase in prevalence of dry eye disease, promising pipeline for dry eye disease and side effects of other medications will drive growth. Factors that could hinder the growth of the dry eye medication market in the future include long and costly drug approvals, stringent rules and regulations and disruption in the supply chain of drugs related to dry eyes due to the impact of covid-19.

Top Companies: Allergan plc (NYSE: AGN).; Alcon Inc; Bausch Health Companies Inc.; Novartis AG; Otsuka Holdings Co, Ltd

Get a sample copy Of this Report:

https://www.marketinsightsreports.com/reports/06022059444/dry-eye-medication-global-market-opportunities-and-strategies-to-2030-covid-19-impact-and-recovery-including-by-type-of-product-aqueous-evaporative-aqueous-and-evaporative-by-prescription-type-otc-drugs-prescription-drugs-by-distribution-channel-hospital-pharmacies-eye-health-clinics-retail-pharmacies-online-pharmacies-by-drug-variation-branded-drugs-generic-drugs-covering-allergan-plc-alcon-inc-bausch-health-companies-inc-novartis-ag-otsuka-holdings-co-ltd/inquiry?Mode=31&OP

The global dry eye medication market is expected to decline from $3,727.5 million in 2019 to $2919.9 million in 2020 at a compound annual growth rate (CAGR) of -22%. The market is then expected to recover and grow at a CAGR of 6.5% from 2021 and reach $5,047.9 million in 2023. The market is expected to grow at a CAGR of 7.1% to nearly $5,794.7 million by 2025, and at a CAGR of 6.9% to $8,078.4 billion by 2030.

Industry News:

Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care

Basel, May 9, 2019: Novartis announced today that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra® (lifitegrast ophthalmic solution) 5% worldwide. Xiidra is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease[2]. The transaction would bolster the Novartis front-of-the-eye portfolio and ophthalmic leadership. Closing of the transaction is expected in second half of 2019, subject to customary closing conditions including regulatory approvals. On closing, Novartis plans a smooth transition of operations and integration of Xiidra into its pharmaceuticals portfolio.

Allergan Expands REFRESH® Portfolio With New REFRESH® REPAIR Lubricant Eye Drops

DUBLIN, July 10, 2018: Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the launch of a new over-the-counter (OTC) artificial tear formulation, REFRESH® REPAIR Lubricant Eye Drops. The first and only artificial tear in the U.S. formulated with carboxymethylcellulose (CMC), hyaluronic acid (HA, an inactive ingredient), and osmoprotectants, REFRESH® REPAIR is the latest addition to the REFRESH® portfolio, the number one doctor-recommended brand of artificial tears. REFRESH® REPAIR tears are designed to repair and protect the eyes from the harmful effects of dry eye and improve clarity of vision.

Key Insights:

The dry eye medication market is segmented by type of product into aqueous, evaporative and aqueous and evaporative. The aqueous and evaporative market was the largest segment of the dry eye medication market, accounting for $3,071 billion or 82% of the total in 2019. The evaporative market is expected to be the fastest-growing segment going forward at a CAGR of 7.5%.

The dry eye medication market is also segmented by type of distribution channel into hospital pharmacies, eye health clinics, retail pharmacies and online pharmacies. The retail pharmacies was the largest segment of the dry eye medication market, accounting for $2,393 million or 64% of the total in 2019. The online pharmacies market is expected to be the fastest-growing segment going forward at a CAGR of 10.7%.

The dry eye medication market is also segmented by type of prescription into OTC drugs and prescription drugs. The OTC drugs was the largest segment of the dry eye medication market, accounting for $2,016 million or 54% of the total in 2019. The prescription drugs market is expected to be the fastest-growing segment going forward at a CAGR of 8.0%.

The dry eye medication market is segmented by drug variation into branded drugs and generic drugs. The branded drugs segment was the largest segment of the ophthalmology drugs market in 2019 at 64.5% or $2,404.2 million. Going forward, the generic drugs is expected to be the fastest-growing segment going forward at a CAGR of 10.0%.

The dry eye medication market is also segmented by delivery system into liquid, gel, ointment and others. The liquid drops were the largest segment of the dry eye medication market, accounting for $3,638 million or 98% of the total in 2019. The eye ointment market is expected to be the fastest-growing segment going forward at a CAGR of 17.3%.

Scope of the Report:

Markets Covered:
By Type Of Product: Aqueous; Evaporative; Aqueous And Evaporative
By Prescription Type: OTC Drugs; Prescription Drugs
By Distribution Channel: Hospital Pharmacies; Eye Health Clinics; Retail Pharmacies; Online Pharmacies
By Delivery System: Liquid; Gel; Ointment; Others
By Drug Variation: Branded Drugs; Generic Drugs

Metrics Covered: Number of Enterprises; Number of Employees

Countries: China, Australia, India, Indonesia, Japan, South Korea, USA, Brazil, France, Germany, Italy, Spain, UK, Russia

Regional Analysis: For a comprehensive understanding of market dynamics, the global Dry Eye Medication Market is analyzed across key geographies namely: United States, China, Europe, Japan, Middle East & Africa, India, and others. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the market.

Explore Full Report With Detailed TOC Here:

https://www.marketinsightsreports.com/reports/06022059444/dry-eye-medication-global-market-opportunities-and-strategies-to-2030-covid-19-impact-and-recovery-including-by-type-of-product-aqueous-evaporative-aqueous-and-evaporative-by-prescription-type-otc-drugs-prescription-drugs-by-distribution-channel-hospital-pharmacies-eye-health-clinics-retail-pharmacies-online-pharmacies-by-drug-variation-branded-drugs-generic-drugs-covering-allergan-plc-alcon-inc-bausch-health-companies-inc-novartis-ag-otsuka-holdings-co-ltd?Mode=31&OP 

North America was the largest region in the dry eye medication market, accounting for 31% of the global market in 2019. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest growing regions in the dry eye medication market will be Middle East and Africa, where growth will be at CAGRs of 15% and 9.4% respectively. These will be followed by the South America and Eastern Europe where the markets are expected to grow at CAGRs of 6.7% and 6.3% respectively.

The global dry eye medication market is fairly concentrated, with a small number of large players. The top ten competitors in the market made up to 78.2% of the total market in 2019. Major players in the market include Allergan plc, Alcon Inc, Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co, Ltd. and others.

The global ophthalmology drugs market, of which the dry eye medication market is a segment, reached a value of nearly $24,640.0 million in 2019, growing at a compound annual growth rate (CAGR) of 6.5% since 2015. It is expected to grow at a CAGR of 7.8% and reach nearly $33,272.8 million by 2023.

The other ophthalmology drugs market was the largest segment in the global ophthalmology drugs market accounting for58.1% of the total in 2019 and is expected to grow the fastest at a CAGR of 9.1% during 2019-2023. The dry eye medication market was the smallest segment in the global ophthalmology drugs market, accounting for 15.1% of the total and was valued at $3,727.5 million in 2019.

The top opportunities in the dry eye medication market segmented by type will arise in aqueous and evaporative segment, which will gain $1,071.1 million of global annual sales by 2023. The top opportunities in the dry eye medication market segmented by distribution channel will arise in the retail pharmacies segment, which will gain $714.9 million of global annual sales by 2023. The top opportunities in the dry eye medication market segmented by type of prescription will arise in the prescription drugs segment, which will gain $796.3 million of global annual sales by 2023.

The dry eye medication market size will gain the most in USA at $336.7 million. Market-trend-based strategies for the dry eye medication market include investing in research and development of new and advanced drugs, develop innovative drugs to survive in the market, develop non-steroidal anti-inflammatory ophthalmic drugs for the treatment of dry-eye syndrome, and develop combination therapies for the treatment of dry eye diseases.

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

–Analytical Tools: The Global Dry Eye Medication Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Finally, The Dry Eye Medication Market report is the believable source for gaining Market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and Market development rate and figure, and so on. This report additionally Present a new task SWOT examination, speculation attainability investigation, and venture return investigation.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com|irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.